On this page
Immune modulation: a research direction
Researchers are studying how immune cells, inflammatory signals and the way cells use energy interact in endometriosis. Immune modulation means changing immune activity. Treatments designed specifically to target these pathways may offer future possibilities, but they are not yet established routine treatments for endometriosis.
Could GLP-1 medicines have a future role?
GLP-1 medicines influence appetite and blood sugar regulation. Related medicines, including tirzepatide, which acts on both GLP-1 and GIP receptors, are used for certain people with diabetes or for weight management.
Researchers have proposed that their effects on metabolic and inflammatory pathways might also matter in endometriosis. Ideas involving immune signalling and inflammation in the nervous system are largely drawn from other conditions and experimental models. They are a reason to investigate, rather than proof of benefit.
No reliable randomised trial evidence currently establishes GLP-1 medicines as an effective endometriosis treatment. They are not licensed for this purpose, and reports of feeling better do not show whether they treat the disease itself.
These medicines have important side effects and need medical supervision. They should not be used during pregnancy or while trying to conceive. If you take one for another condition, discuss pregnancy plans and contraception with your prescriber; tirzepatide needs particular advice for people using the contraceptive pill. Read the MHRA guidance on GLP-1 medicines.
What this means for your care
You can ask about relevant clinical trials. Participation is optional and depends on eligibility and availability. Explore our research and evidence summaries.
Return to established treatment and long-term endometriosis care.
Information sources
- WHO: endometriosis and its wider impact
- Jacobsen and colleagues: a GLP-1/GIP hypothesis, not a treatment trial (2026)
- Endometriosis UK: GLP-1 medicines and the current evidence
- MHRA: GLP-1 medicines, licensed uses and safety
General information to support your consultation. Individual assessment is needed to decide on treatment.